UPB   $5.36  3.68% Market Closed After Close 5.34 -0.37%

Upstream Bio, Inc.

Current temperature: 2.58
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 5
Target Price Mean 34.00
Mean unverified/preliminary 34.00 / 34.00
Target Price Low / High 15.00 / 75.00
Median / STD DEV 25.00 / 24.25
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell None Sell
rsi Sell Buy None
macd None ActivelyBuy None
stoch ActivelyBuy None None
ma20 Sell Sell None
ma50 Sell None None
ma100 None Buy Sell
Candlestick PatternSept. 24, 2026 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US91678A1079
ceo Dr. E. Rand Sutherland M.D., M.P.H., MPH
Website https://upstreambio.com
Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders. It develops verekitug, a monoclonal antibody that targets and inhibits the thymic stromal lymphopoietin receptor. The company also develops therapies to treat severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Upstream Bio, Inc. was incorporated in 2021 and is based in Waltham, Massachusetts.